Mount Sinai Innovation Partners Mount Sinai Innovation Partners Mount Sinai Innovation Partners Mount Sinai Innovation Partners
  • Get Started
    • Disclose a Technology
    • Request an Agreement
    • Search Technologies
    • Contact Your Representative
  • About Us
    • Our Mission
    • Our Impact
      • Technologies
      • Startup Companies
    • Our Team
    • Our Partners
  • Programs
    • Elementa Labs
    • Entrepreneurship Program
    • Fellows Program
    • i3 Funding
      • i3 Prism
      • i3 Genesis
      • i3 Accelerator
    • External Collaborations
  • Resources
    • Innovation Guide
    • Drug Discovery Guide
    • Local Resources
    • Institutional Policies
    • Frequently Asked Questions (FAQs)
  • Discover More
    • News
    • Events
    • Videos
  • Careers
    • Explore Career Opportunities
  • Mount Sinai Health System
    • MountSinai.org
    • Search Faculty
    • Clinical Trials
    • Donations & Gifts
    • Faculty Consulting
Medical Device

GENIPIN-CROSSLINKED FIBRIN HYDROGEL FOR SOFT TISSUE REPAIR

May 14, 2014

The genipin-crosslinked fibrin hydrogel (FibGen) is a stiff, biocompatible hydrogel intended to fill tissue defects in load bearing tissue, and this particular formulation has the addition of fibronectin or collagen to enhance cell viability, proliferation and phenotypic characteristics. Dr. James Iatridis and …

Read full post
Therapeutic

ANTIBODIES TARGETING FOLLICLE STIMULATING HORMONE FOR USE IN OSTEOPOROSIS TREATMENT AND PREVENTION

May 02, 2014

A new paradigm for osteoporosis prevention and treatment was described by Dr. Mone Zaidi, Director of the Mount Sinai Bone Program at the Icahn School of Medicine at Mount Sinai.  By blocking follicle-stimulating hormone (FSH) in pre-clinical models of menopause using an …

Read full post
Therapeutic

NOVEL METHOD TO SPECIFICALLY INHIBIT CATHEPSIN K COLLAGENOLYTIC ACTIVITY

March 19, 2014

Bone homeostasis is a complex process and requires a balance between bone formation and resorption.  Cathepsin K is a collagenase which is highly expressed in bone resorbing cells and its deficiency leads to pycnodysostosis, a rare disease characterized by a decrease in …

Read full post

Mount Sinai Health System

The Mount Sinai Health System is an integrated health care system providing exceptional medical care to our local and global communities.

Read More

Contact MSIP

MSIPInfo@mssm.edu

For technology and research inquiries: visit Contact Your Representative or Contact MSIP

 

Follow Us

  • LinkedIn
  • Facebook
  • X
  • YouTube

Stay Updated

Sign up for the MSIP mailing list

Mount Sinai Innovation Partners © Copyright 2025

  • Privacy Policy
  • Terms & Conditions
  • Non-Discrimination Notice
  • Get Started
    • Disclose a Technology
    • Request an Agreement
    • Search Technologies
    • Contact Your Representative
  • About Us
    • Our Mission
    • Our Impact
      • Technologies
      • Startup Companies
    • Our Team
    • Our Partners
  • Programs
    • Elementa Labs
    • Entrepreneurship Program
    • Fellows Program
    • i3 Funding
      • i3 Prism
      • i3 Genesis
      • i3 Accelerator
    • External Collaborations
  • Resources
    • Innovation Guide
    • Drug Discovery Guide
    • Local Resources
    • Institutional Policies
    • Frequently Asked Questions (FAQs)
  • Discover More
    • News
    • Events
    • Videos
  • Careers
    • Explore Career Opportunities
  • Mount Sinai Health System
    • MountSinai.org
    • Search Faculty
    • Clinical Trials
    • Donations & Gifts
    • Faculty Consulting

Hit enter to search or ESC to close